Genetic analysis of inherited antithrombin deficiency in 18 Polish families;Podłoże genetyczne wrodzonego niedoboru antytrombiny w 18 polskich rodzinach

Acta Haematologica Polonica

Volumn 42, Issue 3, 2011, Pages 519-524

  Odnoczko, Edyta ^a   Vertun Baranowska, B ^a   Buczma, A ^a   Stefanska Windyga E ^a   Oldenburg, J ^b   Windyga, J ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Instytut Hematologii Eksperymentalnej I Transfuzjologii W Bonn   (Germany)

Author keywords

Antithrombin; Inherited antithrombin deficiency; SERPINC1; Trombophilia; VTE

Indexed keywords

ANTITHROMBIN;

ANTITHROMBIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FAMILY STUDY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; POLAND; PROGNOSIS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 80755189500     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Perry DJ, Carrell RW. Molecular genetics of human antithrombin deficiency. Human Mutation 1996; 7: 7-22. (Pubitemid 26002082)
2. van Boven HH, Vandenbroucke JP, Briet E, Rosendaal FR. Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. Blood 1999; 94: 2590-4. (Pubitemid 29477287)
3. Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia 2008; 14: 1229-39.
4. Mahmoodi BK, Brouwer JLP, Ten Kate MK i wsp. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. Journal of Thrombosis and Haemostasis 2010; 8: 1193-200.
5. Sanson BJ, Simioni P, Tormene D. i wsp. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study. Blood 1999; 94: 3702-6.
6. Vossen CY, Conard J, Fontcuberta J i wsp. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis 2005; 3: 459-64.
7. Lane DA, Bayston T, Olds RJ i wsp. Antithrombin mutation database: 2nd (1997) update - For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thrombosis and Haemostasis 1997; 77: 197-211.
8. Perry DJ. Antithrombin and its inherited deficiencies. Blood Reviews 1994; 8: 37-55.
9. Bucciarelli P, Rosendaal FR, Tripodi A i wsp. Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study. Arteriosclerosis Thrombosis and Vascular Biology 1999; 19: 1026-33.
10. Luxembourg B, Delev D, Geisen C i wsp. Molecular basis of antithrombin deficiency. Thrombosis and Haemostasis 2011; 105: 635-46.
11. Picard V, Chen JM, Tardy B i wsp. Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency. Human Genetics 2010; 127: 45-53.
12. Steiner M, Steiner B, Rolfs A i wsp. Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology. Annals of Hematology 2005; 84: 56-8.
13. Tripodi A, Mannucci PM. Laboratory investigation of thrombophilia. Clinical Chemistry 2001; 47: 1597-606. (Pubitemid 32781572)
14. Jennings I, Cooper P. Screening for thrombophilia: a laboratory perspective. British Journal of Biomedical Science 2003; 60: 39-51. (Pubitemid 36384750)
15. Ungerstedt JS, Schulman S, Egberg N i wsp. Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients? Blood 2002; 99: 2271-2.